Profil:
Sopharma ADSOPHARMA AD (147/2024) Decision on additional contribution to the capital of Sopharma Rus OOO
Report no 147/2024
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
Sofia, Bulgaria, December 20, 2024 - In accordance with the requirements of Art. 100t of the LPOS, Sopharma AD (SFA: Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) hereby informs that in order to ensure operational opportunities for growth and increase sales on the traditional markets where the Company operates, the Board of Directors has decided to make an additional contribution to its subsidiary "Sopharma Rus" OOO in the amount of EUR 12.3 million, not increasing the capital.
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz